Exhaled nitric oxide (NO) production, upregulated by inflammatory cytokines and mediators
in central and peripheral airways, can be easily and non-invasively detected in exhaled air …

Pulmonary arterial hypertension (PAH) is a severe disease with a resultant increase of the
mean pulmonary arterial pressure, right ventricular hypertrophy and eventual death …

Fractional exhaled nitric oxide (FeNO) is a well-known and widely accepted biomarker of
airways inflammation that can be useful in the therapeutic management, and adherence to …

Idiopathic pulmonary arterial hypertension (IPAH) is a serious and fatal disease. Recently,
m6A has been reported to play an important role in the lungs of IPAH patients and …

The variable nature of vascular dysfunction in diabetes is not well understood. We explored
the functional adaptation of different arteries in db/db mice in relation to increased severity …

Background Fractional exhaled nitric oxide (FeNO) has been extensively studied in various
causes of pulmonary hypertension (PH), but its utility as a noninvasive marker remains …

Lung transplantation (LT) has been an effective treatment for carefully selected children with
end-stage lung diseases. The aim of this retrospective study is to introduce our experience …

Objectives: To examine the associations between 6-minute walk test (6MWT) and lung
functions, blood gas analysis findings, fractional exhaled nitric oxide (FeNO), and hospital …

Nitric oxide (NO) is a gasotransmitter that plays a vital role in diverse biological processes.
NO is a fundamental component in regulating cardiovascular functions, smooth muscle tone …

Metabolic syndrome (Met-S) is an interrelated complex disease which involves physical,
metabolic and endocrinal dysfunction and is associated with increased risk of …